List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 144 studies with search of:   "Formoterol"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: COPD
Interventions: Drug: Arformoterol tartrate inhalation solution;   Drug: Arformoterol tartrate inhalation solution;   Drug: Arformoterol tartrate inhalation solution;   Drug: Placebo;   Drug: Arformoterol tartrate inhalation solution;   Drug: Arformoterol tartrate inhalation solution;   Drug: Arformoterol tartrate inhalation solution;   Drug: Placebo
2 Completed Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
Condition: COPD
Interventions: Drug: Racemic formoterol;   Drug: Arformoterol tartrate inhalation solution;   Drug: Racemic formoterol
3 Recruiting Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate MDI (MF MDI);   Drug: Formoterol MDI;   Drug: Placebo
4 Recruiting Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate MDI (MF MDI);   Drug: Formoterol MDI;   Drug: Placebo
5 Completed Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD
Conditions: Chronic Obstructive Pulmonary Disease;   Chronic Bronchitis;   Emphysema
Interventions: Drug: arformoterol tartrate inhalation solution;   Drug: arformoterol tartrate inhalation solution;   Drug: arformoterol tartrate inhalation solution;   Drug: Salmeterol;   Drug: Placebo
6 Completed Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Bronchitis;   Emphysema
Interventions: Drug: Arformoterol tartrate inhalation solution;   Drug: Arformoterol 25 ųg BID;   Drug: Formoterol 12 ųg BID;   Drug: Placebo
7 Completed A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: COPD
Interventions: Drug: Arformoterol tartrate inhalation solution;   Drug: Arformoterol tartrate inhalation solution;   Drug: Arformoterol tartrate inhalation solution;   Drug: Salmeterol MDI;   Drug: Placebo
8 Withdrawn Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
Conditions: Chronic Obstructive Pulmonary Disease;   COPD;   Chronic Bronchitis;   Emphysema
Intervention: Drug: formoterol fumarate
9 Completed Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-Dose Inhaler (pMDI) or Oxis Turbuhaler
Condition: Stable Asthma
Interventions: Drug: budesonide/formoterol;   Drug: formoterol
10 Recruiting Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)
Conditions: Asthma;   Airway Inflammation
Interventions: Drug: mometasone furoate/formoterol 100/10 mcg;   Drug: mometasone furoate/formoterol 200/10 mcg;   Drug: mometasone furoate/formoterol 400/10 mcg;   Drug: MF DPI 200 mcg;   Drug: MF MDI 200 mcg;   Drug: Placebo
11 Completed Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
Condition: Bronchial Asthma
Interventions: Drug: beclomethasone dipropionate plus formoterol fumarate combination;   Drug: budesonide plus formoterol combination
12 Active, not recruiting Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium Bromide and Formoterol Fumarate fixed-dose combination (FDC);   Drug: Aclidinium Bromide and Formoterol Fumarate fixed-dose combination (FDC);   Drug: Formoterol Fumarate
13 Not yet recruiting Dose-Response of Inhaled Formoterol
Condition: Asthma
Interventions: Procedure: formoterol;   Procedure: formoterol
14 Recruiting Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma
Condition: Asthma
Interventions: Drug: MFF258 (mometasone furoate/formoterol fumarate);   Drug: formoterol fumarate;   Drug: formoterol fumarate;   Drug: placebo
15 Recruiting Study to Evaluate the Additional Effects of Tiotropium Plus Formoterol on Chronic Obstructive Pulmonary Disease (COPD) During Exercise
Conditions: Pulmonary Disease, Chronic Obstructive;   COPD;   Chronic Bronchitis;   Pulmonary Emphysema
Interventions: Drug: Formoterol;   Drug: Formoterol+Tiotropium
16 Recruiting Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)
Condition: Exercise-Induced Bronchospasm
Interventions: Drug: arformoterol;   Drug: formoterol;   Drug: placebo
17 Recruiting Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Formoterol Turbuhaler 4.5mg;   Drug: Formoterol Turbuhaler 9 mg;   Drug: Turbuhaler placebo
18 Recruiting A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
Condition: Acute Asthma
Interventions: Drug: arformoterol (RR formoterol);   Drug: placebo;   Drug: levalbuterol
19 Completed Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)
Condition: Asthma
Interventions: Drug: mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID;   Drug: Mometasone furoate MDI (MF MDI);   Drug: formoterol fumarate 10 mcg;   Drug: Placebo
20 Completed Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)
Condition: Asthma
Interventions: Drug: mometasone furoate/formoterol fumarate combination MDI 100/10 mcg BID;   Drug: Mometasone furoate MDI (MF MDI);   Drug: formoterol fumarate 10 mcg;   Drug: Placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services